Calao

Calao S.r.l. is an Italian pharmaceutical company based in Milan that specializes in the supply and distribution of Active Pharmaceutical Ingredients (APIs) and intermediates. Founded in 2012, the company serves as a strategic partner for global pharmaceutical manufacturers by providing high-quality chemical components for drug formulation. Their product portfolio includes a wide range of established molecules such as Buflomedil, Glibenclamide, Gliclazide, and Ofloxacin. Calao operates primarily as a distributor and agent, ensuring regulatory compliance and quality standards for the ingredients it sources and supplies to the healthcare industry.